These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33225644)
21. Isolation of Acinetobacter species from Clinical Specimens with Detection of Their Antimicrobial Susceptibility Pattern from a Tertiary Care Hospital, Bangladesh. Ifa IA; Paul SK; Hossain MA; Haque N; Ahmed S; Nasreen SA; Ahamed F; Roy S; Sakib N; Abedin S; Kobayashi N Mymensingh Med J; 2020 Jul; 29(3):622-627. PubMed ID: 32844803 [TBL] [Abstract][Full Text] [Related]
22. OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey. Cakirlar FK; Ciftci IH; Gonullu N Clin Lab; 2015; 61(7):741-7. PubMed ID: 26299073 [TBL] [Abstract][Full Text] [Related]
23. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii. Dong X; Chen F; Zhang Y; Liu H; Liu Y; Ma L J Antibiot (Tokyo); 2014 Sep; 67(9):677-80. PubMed ID: 25095805 [TBL] [Abstract][Full Text] [Related]
24. Can Pharmacokinetic and Pharmacodynamic Principles Be Applied to the Treatment of Multidrug-Resistant Acinetobacter? Cooper TW; Pass SE; Brouse SD; Hall RG Ann Pharmacother; 2011 Feb; 45(2):229-40. PubMed ID: 21304038 [TBL] [Abstract][Full Text] [Related]
25. In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore. Lim TP; Tan TY; Lee W; Sasikala S; Tan TT; Hsu LY; Kwa AL J Antibiot (Tokyo); 2009 Dec; 62(12):675-9. PubMed ID: 19876075 [TBL] [Abstract][Full Text] [Related]
26. Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review. Poulikakos P; Tansarli GS; Falagas ME Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1675-85. PubMed ID: 24832022 [TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of antibiotic co-resistance among carbapenem resistant Acinetobacter baumannii. Khurshid M; Rasool MH; Siddique MH; Azeem F; Naeem M; Sohail M; Sarfraz M; Saqalein M; Taj Z; Nisar MA; Qamar MU; Shahzad A J Infect Dev Ctries; 2019 Oct; 13(10):899-905. PubMed ID: 32084020 [TBL] [Abstract][Full Text] [Related]
29. Bloodstream infections caused by Acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors. Park GE; Kang CI; Cha MK; Cho SY; Seok H; Lee JH; Kim JY; Ha YE; Chung DR; Peck KR; Lee NY; Song JH Int J Infect Dis; 2017 Sep; 62():26-31. PubMed ID: 28676346 [TBL] [Abstract][Full Text] [Related]
30. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602 [TBL] [Abstract][Full Text] [Related]
31. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Bahador A; Taheri M; Pourakbari B; Hashemizadeh Z; Rostami H; Mansoori N; Raoofian R Microb Drug Resist; 2013 Oct; 19(5):397-406. PubMed ID: 23768166 [TBL] [Abstract][Full Text] [Related]
32. [Antimicrobial susceptibility and molecular characterization of multidrug-resistant Acinetobacter baumannii isolated in an university hospital]. Direkel Ş; Çopur Çiçek A; Karagöz A; Aydoğan Ejder N; Oktay E; Delialioğlu N; Özgümüş OB; Durmaz R Mikrobiyol Bul; 2016 Oct; 50(4):522-534. PubMed ID: 28124957 [TBL] [Abstract][Full Text] [Related]
33. [Analysis of drug resistance of Liu S; Wang C; Fu YX Zhonghua Shao Shang Za Zhi; 2017 Jul; 33(7):404-409. PubMed ID: 28763905 [No Abstract] [Full Text] [Related]
34. Emergence of Aminoglycoside Resistance Due to armA methylase in Multi-drug Resistant Acinetobacter Baumannii Isolates in a University Hospital in Nepal. Shrestha S; Tada T; Shrestha B; Kirikae T; Ohara H; Rijal BP; Pokhrel BM; Sherchand JB J Nepal Health Res Counc; 2016 May; 14(33):72-76. PubMed ID: 27885285 [TBL] [Abstract][Full Text] [Related]
35. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial. Zhang Z; Chen M; Yu Y; Pan S; Liu Y Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308 [TBL] [Abstract][Full Text] [Related]
36. Amikacin-resistant Acinetobacter species mediated by the aphA6 gene associated with clinical outcome at an academic complex hospital in KwaZulu-Natal Province, South Africa. Swe Swe-Han K; Pillay M; Pillay M S Afr Med J; 2019 Dec; 110(1):49-54. PubMed ID: 31865943 [TBL] [Abstract][Full Text] [Related]
37. Influence of regular reporting on local Pseudomonas aeruginosa and Acinetobacter spp. sensitivity to antibiotics on consumption of antibiotics and resistance patterns. Djordjevic ZM; Folic MM; Jankovic SM J Clin Pharm Ther; 2017 Oct; 42(5):585-590. PubMed ID: 28556289 [TBL] [Abstract][Full Text] [Related]
38. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features. Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK; Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519 [TBL] [Abstract][Full Text] [Related]
39. Comparison of tigecycline susceptibility testing methods for multidrug-resistant Acinetobacter baumannii. Idelevich EA; Freeborn DA; Seifert H; Becker K Diagn Microbiol Infect Dis; 2018 Aug; 91(4):360-362. PubMed ID: 29778562 [TBL] [Abstract][Full Text] [Related]
40. Previous Antibiotic Exposure and Antimicrobial Resistance Patterns of Djordjevic ZM; Folic MM; Jankovic SM Balkan Med J; 2017 Dec; 34(6):527-533. PubMed ID: 29215335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]